CSIMarket
 


Alexion Pharmaceuticals Inc   (ALXN)
Other Ticker:  
 

Alexion Pharmaceuticals Inc 's Quick Ratio

ALXN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




ALXN Quick Ratio (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Current Liabilities Change 27.35 % 36.04 % 21.98 % 8.59 % 18.66 %
Y / Y Cash & cash equivalent Change 46.83 % 9.09 % 3.66 % 36.48 % 42.76 %
Quick Ratio MRQ 2.43 1.85 1.73 2.55 2.11
Overall Ranking # # # # #
Seq. Current Liabilities Change -12.22 % 22.07 % 18.83 % 0.02 % -6.23 %
Seq. Cash & cash equivalent Change 15.67 % 30.58 % -19.46 % 20.7 % -14.06 %



Quick Ratio first quarter 2021 Comment
Alexion Pharmaceuticals Inc 's Cash & cash equivalent grew by 15.67 % in I. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Alexion Pharmaceuticals Inc 's Quick Ratio to 2.43, Quick Ratio remained below Alexion Pharmaceuticals Inc average.

Within Major Pharmaceutical Preparations industry 257 other companies have achieved higher Quick Ratio than Alexion Pharmaceuticals Inc in first quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are ALXN Segments?
See Quick Ratio ALXN on the trailing twelve month basis
Quick Ratio first quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 258
Healthcare Sector # 560
Overall Market # 1355


Quick Ratio Statistics
High Average Low
4.29 2.31 1.13
(Dec 31 2013)   (Jun 30 2018)




Financial Statements
Alexion Pharmaceuticals Inc 's Current Liabilities $ 1,426 Millions Visit ALXN's Balance sheet
Alexion Pharmaceuticals Inc 's Cash & cash equivalent $ 3,469 Millions Visit ALXN's Balance sheet
Source of ALXN's Sales Visit ALXN's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2021, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2021 MRQ Cash & cash equivalentMar 31 2021 MRQ Current Liabilities
Chiasma Inc   6.64 $ 115.033  Millions$ 17.319  Millions
Mersana Therapeutics inc   6.54 $ 228.430  Millions$ 34.919  Millions
9 Meters Biopharma Inc   6.44 $ 38.571  Millions$ 5.987  Millions
Hookipa Pharma inc   6.35 $ 127.716  Millions$ 20.116  Millions
Sesen Bio Inc   6.33 $ 109.965  Millions$ 17.367  Millions
Nurix Therapeutics Inc   6.32 $ 303.073  Millions$ 47.972  Millions
Sarepta Therapeutics Inc   6.31 $ 1,737.833  Millions$ 275.492  Millions
Kintara Therapeutics Inc   6.21 $ 15.718  Millions$ 2.533  Millions
Panbela Therapeutics Inc   6.18 $ 8.098  Millions$ 1.310  Millions
Ionis Pharmaceuticals Inc   6.17 $ 1,819.995  Millions$ 295.105  Millions
Aveo Pharmaceuticals Inc   6.14 $ 121.414  Millions$ 19.773  Millions
Locust Walk Acquisition Corp   6.09 $ 1.468  Millions$ 0.241  Millions
Mirum Pharmaceuticals Inc   6.09 $ 213.113  Millions$ 35.022  Millions
Leap Therapeutics inc   5.88 $ 43.491  Millions$ 7.392  Millions
Tricida Inc   5.75 $ 217.731  Millions$ 37.864  Millions
Entasis Therapeutics Holdings Inc   5.59 $ 44.937  Millions$ 8.033  Millions
Vyne Therapeutics Inc   5.59 $ 120.398  Millions$ 21.549  Millions
Fortress Biotech Inc   5.58 $ 289.897  Millions$ 51.980  Millions
Vallon Pharmaceuticals Inc   5.57 $ 12.980  Millions$ 2.332  Millions
Amarin Corp Plcuk  5.50 $ 518.653  Millions$ 94.262  Millions
Maravai Lifesciences Holdings Inc   5.38 $ 247.675  Millions$ 46.077  Millions
Acadia Pharmaceuticals Inc   5.28 $ 577.768  Millions$ 109.373  Millions
Corbus Pharmaceuticals Holdings Inc   5.25 $ 124.012  Millions$ 23.605  Millions
Sigilon Therapeutics Inc   5.19 $ 178.789  Millions$ 34.479  Millions
Chimerix inc   5.07 $ 112.898  Millions$ 22.248  Millions
Insmed Inc  5.03 $ 409.751  Millions$ 81.397  Millions
Eyegate Pharmaceuticals inc   4.92 $ 6.610  Millions$ 1.343  Millions
Bellerophon Therapeutics inc  4.92 $ 39.774  Millions$ 8.087  Millions
Benitec Biopharma Inc   4.91 $ 11.997  Millions$ 2.444  Millions
Corvus Pharmaceuticals Inc   4.88 $ 67.969  Millions$ 13.916  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

YUMM's Profile

Stock Price

YUMM's Financials

Business Description

Fundamentals

Charts & Quotes

YUMM's News

Suppliers

YUMM's Competitors

Customers & Markets

Economic Indicators

YUMM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071